MG-53

N/A

Report date: 2022/11/16 15:34:28

Base Information

Drug NameMG-53
Drug Alias NameMG-53
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionMitsugumin-53 replacements
TargetsMitsugumin-53
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPeking UniversityHope Medicine (Nanjing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPeking UniversityHope Medicine (Nanjing) Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A